橫向流動化驗市場規模、佔有率、成長分析、按產品類型、按方法、按樣本類型、按應用、按最終用戶、按地區行業預測，2024-2031 年

2022年全球橫向流動化驗市場規模為92億美元，從2023年的99.1億美元成長到2031年的179.4億美元，在預測期內（2024-2031年）預計年複合成長率為7.7。

橫向流動化驗(LFA) 或免疫測量是使用者友善的診斷工具，對於快速檢測目標分析物至關重要，例如食品、水和飼料中的污染物，以及人類和動物病原體和生物標記。 LFA 因其在妊娠檢測中的應用而廣受認可，也支持傳染病檢查、藥物濫用篩檢和快速心臟標記診斷。這些測試不需要水、電或專門培訓，並提供快速、經濟高效的分析結果。 LFA 具有清晰的測試和控制線，以確保功能性，並且與讀取器技術結合時可以量化。其靈活性使得能夠在各種環境下就地檢驗，這對於解決醫療保健准入挑戰至關重要，特別是在新興市場，並且是市場發展的驅動力。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境
• 專利分析
• 案例研究

橫向流動化驗市場規模：依產品及年複合成長率（2024-2031）

• 市場概況
• 試劑套件和試劑
• 領導者
  • 數位/手持閱讀器
  • 替補最高領導者

橫向流動化驗市場規模：依技術及年複合成長率（2024-2031）

• 市場概況
• 夾心法
• 競爭性測定
• 多重檢測分析

橫向流動化驗市場規模：依樣本類型及年複合成長率（2024-2031）

• 市場概況
• 血液樣本
• 尿液樣本
• 唾液樣本
• 其他樣品

橫向流動化驗市場規模：依應用與年複合成長率（2024-2031）

• 市場概況
• 臨床檢查
  • 傳染病檢查
  • 心臟標記測試
  • 妊娠及不孕症檢測
  • 膽固醇/血脂測試
  • 藥物濫用測試
  • 其他實驗室測試
• 獸醫診斷
• 食品安全及環保檢驗
• 藥品開發與品質檢驗

橫向流動化驗市場規模：依最終用戶及年複合成長率（2024-2031）

• 市場概況
• 醫院/診所
• 居家照護
• 診斷實驗室
• 製藥和生物技術公司
• 其他

橫向流動化驗市場規模及年複合成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
• 產品系列分析
• 按細分市場分類的佔有率分析
• 收益與前一年同期比較（2021-2023）

主要企業簡介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• QuidelOrtho Corporation
• Danaher Corporation
• Siemens AG
• Becton, Dickinson and Company
• Biomerieux SA
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Qiagen NV
• Merck KGaA
• Hologic, Inc.
• Abcam plc
• Surmodics Inc.
• Chembio Diagnostics, Inc.（Biosynex）
• Orasure Technologies
• DCN Diagnostics
• Polysciences Inc.
• Abingdon Health
• Oranoxis Inc.
• Aesku.Group GmbH
• Bio Group Medical System SRL

結論和建議

Global Lateral Flow Assays Market size was valued at USD 9.2 billion in 2022 and is poised to grow from USD 9.91 billion in 2023 to USD 17.94 billion by 2031, growing at a CAGR of 7.7% during the forecast period (2024-2031).

Lateral flow assays (LFAs), or immunoassays, are user-friendly diagnostic tools essential for rapid detection of target analytes, including contaminants in food, water, and animal feed, as well as pathogens and biomarkers in humans and animals. Widely recognized for their applications in pregnancy tests, LFAs also cater to infectious disease testing, drug misuse screening, and rapid cardiac marker diagnostics. These tests operate without the need for water, power, or specialized training, offering quick and cost-effective analytical results. LFAs feature clear test and control lines for functionality assurance and can be quantitative when paired with reader technology. Their flexibility enables point-of-care testing across various environments, making them pivotal in addressing healthcare accessibility challenges, particularly in developing regions, thus driving market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Flow Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Flow Assays Market Segmental Analysis

Global Lateral Flow Assays Market is segmented by Product, Technique, Sample Type, Application, End User, and region. Based on Product, the market is segmented into Kits & Reagents, Readers. Based on Technique, the market is segmented into Sandwich assays, Competitive assays, Multiplex detection assays. Based on Sample Type, the market is segmented into Blood samples, Urine samples, Saliva samples, and Other samples. Based on Application, the market is segmented into Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, Drug Development & Quality Testing. Based on End User, the market is segmented into Hospitals & clinics, Home care settings, Diagnostic laboratories, Pharmaceutical & biotechnology companies, and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Flow Assays Market

A significant factor driving the growth of the global lateral flow assays market is the increasing adoption of lateral flow devices in home healthcare settings. Their user-friendly nature, portability, and ability to deliver rapid results without requiring additional equipment or medical expertise have led to a surge in the use of these devices since their inception. Additionally, the fact that these tests can be obtained without a prescription is further enhancing their popularity and supporting market growth. Other contributing elements include the presence of reimbursement organizations, funding initiatives, collaborations between major pharmaceutical companies, and ongoing technological advancements, all of which are expected to elevate the demand for lateral flow rapid diagnostic tests.

Restraints in the Global Lateral Flow Assays Market

The growth of the global lateral flow assays market is hindered by several key constraints. One significant issue is the relatively low precision of results produced by lateral flow tests compared to laboratory testing, which medical professionals often prefer due to its higher accuracy. Additionally, the high costs associated with lateral flow assays pose a substantial barrier to market proliferation, particularly in low-income regions. In such areas, limited awareness and a shortage of skilled professionals further exacerbate these challenges, restricting the widespread adoption and acceptance of lateral flow tests and ultimately inhibiting market expansion.

Market Trends of the Global Lateral Flow Assays Market

The Global Lateral Flow Assays market is witnessing remarkable growth driven by the increasing demand for rapid and reliable testing methods across various sectors, particularly in food quality monitoring. As food safety regulations become more stringent due to rising public health concerns over contamination risks from toxins, heavy metals, and adulterants, the adoption of lateral flow assays as "quick tests" is on the rise. Their ability to deliver rapid, single-use results enhances efficiency in detecting contaminants and residues in food products, beverages, and dairy. This trend is further supported by the growing analytical community's preference for simple and cost-effective detection methodologies, positioning lateral flow assays as a pivotal tool in ensuring food safety and quality worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Lateral Flow Assays Market Size by Product & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
• Readers
  • Digital/Handheld Readers
  • Benchtop Readers

Global Lateral Flow Assays Market Size by Technique & CAGR (2024-2031)

• Market Overview
• Sandwich assays
• Competitive assays
• Multiplex detection assays

Global Lateral Flow Assays Market Size by Sample Type & CAGR (2024-2031)

• Market Overview
• Blood samples
• Urine samples
• Saliva samples
• Other samples

Global Lateral Flow Assays Market Size by Application & CAGR (2024-2031)

• Market Overview
• Clinical Testing
  • Infectious Disease Testing
  • Cardiac Marker Testing
  • Pregnancy & Fertility Testing
  • Cholesterol/Lipid Testing
  • Drugs-of-abuse Testing
  • Other Clinical Tests
• Veterinary Diagnostics
• Food Safety & Environment Testing
• Drug Development & Quality Testing

Global Lateral Flow Assays Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals & clinics
• Home care settings
• Diagnostic laboratories
• Pharmaceutical & biotechnology companies
• Other end users

Global Lateral Flow Assays Market Size & CAGR (2024-2031)

• North America (Product, Technique, Sample Type, Application, End User)
  • US
  • Canada
• Europe (Product, Technique, Sample Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Technique, Sample Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Technique, Sample Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technique, Sample Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surmodics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostics, Inc. (Biosynex)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orasure Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DCN Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polysciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abingdon Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oranoxis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesku.Group GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Group Medical System S.R.L
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation